CD274 and neoplasm: Whilst PDL1 expression, tumour mutational burden (TMB) and Interferon‐gamma are thought to be predictive of response rates, these features have not been consistent across tumour types, demonstrate temporal and spatial heterogeneity49 and can change with multiple treatment lines.